Ranbaxy, Lupin may add 8-10%: Ashish Chaturmohta

Ashish Chaturmohta of Fortune Equity Brokers told CNBC-TV18, "The trend will continue to be on the upside because in terms of rollovers we have seen a very significant addition of position in auto, capital goods and IT space. Even in the capital goods space, most of the midcap stocks like Voltas or Crompton Greaves, there we have seen a very significant addition of built-up."

He further added, "As far as Larsen and Toubro (L&T) and Bharat Heavy Electricals (BHEL) are concerned we have seen a very decent rise in the open interest addition. So these are the stocks where we may see the trend continuing on the upside."

"In the pharma space, Ranbaxy and Lupin look good for a 8-10 percent upside from current levels. As far as auto is concerned, Maruti Suzuki will be our pick where we have seen a very significant addition of open interest in the December series. As far as rollovers are concerned it is above average. So I think Maruti Suzuki looks good for a target of Rs 1900 in the January series," Chaturmohta said.